The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Novo Nordisk carries a Zacks Rank #5 (Strong Sell), whereas Amgen carries a Zacks Rank #3 (Hold) at present, which makes AMGN ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

Now, it’s worth noting Stock Advisor’s total average return is 975 % — a market-crushing outperformance compared to 193% for ...

Novo Nordisk A/S (NYSE: NVO) is making headlines as a leading player in the weight-loss drug market, primarily due to its blockbuster medications, Ozempic and Wegovy. With projected sales reaching $17 ...

U.S. stock futures signal a subdued start to trading in the final full session before Christmas, as investors await fresh data on the health of the U.S. economy. Space-related stocks are under ...

A proposed new federal law could provide some competitive guardrails for the company's most important product.

Tesla’s sales across the European Union, the Euro Free Trade Association and the UK dropped 11.8% year-on-year to 22,801 units in November, according to data released Tuesday by the European ...